MarketResearch.biz delivers in-depth insights on the global cancer/tumor profiling market in its upcoming report titled, “Global Cancer/Tumor Profiling Market Trends, Analysis, Growth, and Forecast: 2018 to 2027”. The global cancer/tumor profiling market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global cancer/tumor profiling market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global cancer/tumor profiling market, their financials, supply chain trends, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global cancer/tumor profiling market report has been segmented on the basis of technology, cancer type, application, and region.
Cancer/tumor profiling technique provides genetic information in cancer cell. It also classifies tumors more accurately and helps oncologist to select appropriate therapy for the treatment of cancer. In case of breast cancer, tumor profiling may predict whether the cancer is more likely to recur. The immunohistochemistry (IHC) is a technology used to determine the level of protein expression in a tumor whereas, next-generation sequencing is used to examine and detect mutations in DNA sequences. Thus, the cancer/tumor profiling can avoid the over treatment of cancer patients.
Increasing number of cancer cases globally and increasing funding by several organizations for cancer research are major factors contributing to growth of the global cancer/tumor profiling market. In addition, rise in adoption of the cancer profiling methods by oncologist are other factors contributing to growth of the global cancer/tumor profiling market. Moreover, rising awareness about cancer globally, coupled with several governments and non-profit organizations providing education and support services, is anticipated to further drive growth of the global cancer/tumor profiling market over the forecast period.
A major factor restraining growth of the global cancer/tumor profiling market is high cost for development of biomarkers.
North America market dominates the global cancer/tumor profiling market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to well-developed healthcare infrastructure and availability of skilled medical personnel and increasing number of cancer cases in the region. Europe accounts for second-largest revenue share contribution to the global cancer/tumor profiling market, followed by markets in Latin America, Asia Pacific, and Middle East & Africa respectively. The market in Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to increasing investment by key market players in emerging market and increasing demand for advanced healthcare services.
Global Cancer/Tumor Profiling Market Segmentation:
Global cancer/tumor profiling market segmentation, by technology:
- Next-Generation Sequencing (NGS)
- Quantitative Polymerase Chain Reaction (QPCR)
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Fluorescence In Situ Hybridization (FISH)
- Chromogenic In Situ Hybridization (CISH)
Global cancer/tumor profiling market segmentation, by technique:
Global cancer/tumor profiling market segmentation, by application:
- Clinical Application
- Research Application
Global cancer/tumor profiling market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Illumina, Inc.
- Qiagen N.V.
- Neogenomics Laboratories, Inc.
- HTG Molecular Diagnostics, Inc.
- Genomic Health Inc.
- Caris Life Sciences
- Helomics Corporation
- Nanostring Technologies, Inc.
- Ribomed Biotechnologies, Inc.
- Oxford Gene Technology
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!